Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00FJC
|
||||
Former ID |
DIB001924
|
||||
Drug Name |
Nuvanil
|
||||
Synonyms |
NE-21610
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Discontinued in Phase 2 | [1] | ||
Company |
Procter & Gamble Pharmaceuticals Inc
|
||||
Structure |
![]() |
Download2D MOL |
|||
Canonical SMILES |
c1(c(ccc(c1)CNC(=O)CCCCCCC/C=C\CCCCCCCC)OCCN)OC
|
||||
CAS Number |
CAS 118090-17-8
|
||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Agonist | [2] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
Inflammatory mediator regulation of TRP channels | |||||
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References | |||||
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003434) | ||||
REF 2 | TRPV1: ON THE ROAD TO PAIN RELIEF. Curr Mol Pharmacol. 2008 November; 1(3): 255-269. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.